BioCentury | Nov 25, 2020
Product Development
Data Byte: a snapshot of the clinical cutaneous T cell lymphoma pipeline
...significant adverse events. Synthetic hypericin, the active ingredient in SGX301, accumulates in T cells and targets Hsp90...
...therapy are expected by year-end. TARGETSCCR4 (CD194) – CC chemokine receptor 4HDAC – Histone deacetylaseHsp90 – Heat shock protein 90 IL-2...
...therapy are expected by year-end. TARGETSCCR4 (CD194) – CC chemokine receptor 4HDAC – Histone deacetylaseHsp90 – Heat shock protein 90 IL-2...